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Abstract
It has been proposed that positive selection may be associated with protein functional change. For example, human and
macaque have different outcomes to HIV infection and it has been shown that residues under positive selection in the
macaque TRIM5 receptor locate to the region known to influence species-specific response to HIV. In general, however,
the relationship between sequence and function has proven difficult to fully elucidate, and it is the role of large-scale
studies to help bridge this gap in our understanding by revealing major patterns in the data that correlate genotype with
function or phenotype. In this study, we investigate the level of species-specific positive selection in innate immune genes
from human and mouse. In total, we analyzed 456 innate immune genes using codon-based models of evolution,
comparing human, mouse, and 19 other vertebrate species to identify putative species-specific positive selection.
Then we used population genomic data from the recently completed Neanderthal genome project, the 1000 human
genomes project, and the 17 laboratory mouse genomes project to determine whether the residues that were putatively
positively selected are fixed or variable in these populations. We find evidence of species-specific positive selection on
both the human and the mouse branches and we show that the classes of genes under positive selection cluster by
function and by interaction. Data from this study provide us with targets to test the relationship between positive
selection and protein function and ultimately to test the relationship between positive selection and discordant
phenotypes.
Key words: innate immune evolution, species-specific responses, adaptive evolution, protein functional shift, predicting
phenotypic response.
Introduction
Immunology relies predominately on the mouse as a model
organism. However, there are inconsistencies between
humans and model organisms in terms of immune response
(Mestas and Hughes 2004). For example, protein-coding se-
quence differences in Toll-like receptor 4 (TLR4) have been
shown to produce nickel sensitivity in human but not mouse
(Schmidt et al. 2010). We define these divergent phenotypic
responses as discordant phenotypes. This discordance in
immune response between humans and model organisms
is particularly problematic in clinical trials; for example, the
anti-inflammatory drug TGN1412 reached clinical trial in
2006 following promising results from testing in crab-eating
macaques, but in humans the drug elicited a cytokine storm
and multiple organ failure (Stebbings et al. 2007). Therefore
discordant phenotypic responses to immune system chal-
lenge are evident even between closely related species.
Indeed discordant immune responses between human
and model organisms may not be all that surprising
considering the divergence times of human and mouse for
example and indeed their diverse environments (Mestas and
Hughes 2004). Also, we know that the protein-coding regions
of immune system genes are among the most rapidly
evolving of all genes in the vertebrate genome, with specific
innate immune-related genes such as those involved in
complement-mediated immunity being among the most rap-
idly evolving (Kosiol et al. 2008). The “Red Queen hypothesis”
describes the evolutionary arms race between host and path-
ogen (Van Valen 1973), a dynamic that results in fixation of
selectively advantageous amino acid substitutions (i.e., posi-
tive selection) in immune system genes (Sawyer et al. 2005).
Understanding the relationship between genotype and dis-
cordant phenotypes remains a major goal of modern evolu-
tionary and biomedical research (Kumar et al. 2011).
There are a number of individual cases where positive se-
lection has been associated with functional shift, for example
the SPRY domain of TRIM5 functions as a HIV-1 restriction
factor in rhesus macaque but not in human (Stremlau et al.
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2005) and signatures of positive selection in the rhesus ma-
caque TRIM5 gene in an 11- to 13-amino acid segment of
the SPRY domain have been functionally characterized as
providing this HIV-1 restriction capability (Sawyer et al.
2005). Previously we have shown that using rational muta-
genesis of positively selected residues in the myeloperoxidase
(MPO) protein—an innate immune enzyme produced by
neutrophils of mammals revealed that these residues gov-
erned the unique chlorination function of the MPO
enzyme (Loughran et al. 2012). Although these individual
gene-based studies provide support for a correlation between
predicted positive selection at the sequence level and protein
functional shift, it is clear that further large-scale studies and
complementary in vitro forward mutation of ancestral pro-
teins are needed to advance our understanding of the mo-
lecular nature of adaptation (Yokoyama et al. 2008;
Yokoyama 2013).
We currently have a large number of phylogenetically di-
verse and high-quality vertebrate genomes available (Flicek
et al. 2014). Although species level studies have been con-
ducted on various vertebrate genomes to identify evidence of
positive selection, concerns have been raised that they may
contain false positives due to recombination (Anisimova et al.
2003), alignment error (Fletcher and Yang 2010), and possible
sequence and annotation error (Schneider et al. 2009).
Accounting for such potential sources of error in selective
pressure analyses is essential for results of biological relevance.
We now have population genomic data for human from the
1000 human genomes project, and for mouse from the 17
mouse genomes project (Keane et al. 2011; Abecasis et al.
2012). Population level data has been successfully applied
to identifying proteins associated with adaptation to high-
altitudes in Tibetans (Simonson et al. 2010). Recently, we
have also seen a marked increase in the quality and
number of Neanderthal genomes available (Green et al.
2010). The combination of population level data, ancestral
genome data, and species level comparisons for selective pres-
sure variation enables us to assess whether putatively posi-
tively selected residues are fixed or variable within their
respective populations and potentially allows us to determine
if and when a selective sweep may have happened (Sabeti
et al. 2006).
Combined, these data provide us with a unique oppor-
tunity to compare the evolution of the innate immune
system between human and mouse from two complemen-
tary perspectives: first, from the species comparison level
and then from the population level comparison. At both
levels, we are using estimates of positive selection as a proxy
for potential changes in protein function for further study.
For the species level comparison, we have applied lineage-
specific codon-based models of evolution to estimate the
heterogeneity in selective pressures across species and across
sites in a protein (Yang 2007). Essentially this approach
employs the ratio of replacement substitutions per replace-
ment site (Dn) over silent substitutions per silent site (Ds) to
estimate selective pressures in protein-coding sequences
(Yang 2007). The lineage-specific codon models employed
have been shown to have low levels of false positive
detection using experimental conditions we have adhered
to in our study (Yang and dos Reis 2011). In addition, we
have incorporated filters for recombination and alignment
error to further reduce false positive discovery rates
(Anisimova et al. 2003; Fletcher and Yang 2010). The popu-
lation level approach determined if the positively selected
residues of the putative positively selected genes were fixed
or variable in the corresponding population, specifically we
tested the hypothesis that the putative positive selection
event occurred recently by assessing if the substitution
processes within the population were neutral or nonneutral
(Nei and Li 1979; Tajima 1989).
Teasing apart the relationship between sequence and func-
tion is essential for us to better model human disease and
drugs. Our findings show that there is evidence for species-
specific positive selection in the innate immune system, and
that it is more frequent in mouse than human. We find that a
number of the putative positively selected genes are clustered
into pathways and are associated with known functional dis-
cordance between human and mouse providing us with es-
sential targets for the exploration of the relationship between
genotype, phenotype, and functional discordance. Positive
selection may also result in advantageous alleles becoming
fixed within a population (Haldane 1927). Indeed, we observe
the positively selected residues to be fixed (for the most part)
in their respective modern populations, lending further sup-
port to the hypothesis that they may be under positive se-
lection. The antagonistic coevolutionary relationship between
hosts and pathogens is reported to result in a heightened rate
of molecular evolution and greater genetic divergence of in-
teracting pairs of proteins (Paterson et al. 2010). In our anal-
ysis, we find that the genes under positive selection are
clustered into functional pathways and are part of protein–
protein interactions, indicating that potential coevolutionary
relationships may in fact be a major driving force among
innate immune pathway genes. Our analysis does not include
regulatory related differences and neutral/nearly neutral pro-
cesses that most likely play a role in phenotypic discordance
(McLean et al. 2011). Our analysis is conservative and only
considers proteins with strong signatures for selective pres-
sure, therefore selective forces acting at the pathway level only
will not be detected (Daub et al. 2013). Nonetheless, this
large-scale study of the evolution of innate immune genes
provides the community with an overview of the pathways,
proteins, and specific residues that we predict have under-
gone different selective pressures in the independent evolu-
tion of human and mouse lineages. We present key molecular
targets of genes associated with known species-specific dis-
cordance for further study.
Results
Evidence for Species-Specific Adaptation in Mouse
and Human Innate Immune Genes
The 456 protein-coding gene families were identified using a
data set of human genes reported to be involved in the
innate immune response (Lynn et al. 2008) as query against
a data set of 21 vertebrate genomes (see Materials and
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Methods). Species-specific paralogs were permitted within
these gene families, and a gene family had to contain a min-
imum of seven sequences to be included in the selective
pressure analyses (Anisimova et al. 2003). Following likeli-
hood ratio tests (LRTs) of nested codon models (Yang
2007), we identified a number of candidate genes exhibiting
signatures of positive selection particular to given lineages
(supplementary table S1, Supplementary Material online).
False positive predictions of positive selection have been
shown to be associated with recombination (Anisimova
et al. 2003). To ameliorate the frequency of false positives
any candidate gene that had evidence of recombination
proximal to a positively selected site was removed from
our list of positively selected genes. Following the filter for
recombination, our predictions were as follows: two candi-
date genes exhibiting lineage-specific positive selection
(CARD6 and IRF9) in the human lineages (these two candi-
date genes were from the total of 456 gene families that
contained a human ortholog), and 35 in the mouse lineage
(these 35 genes were from the total of 363 gene families that
contained a mouse ortholog; table 1 and fig. 1).
A Subset of Mouse Innate Immune Pathways Are
Enriched for Adaptive Evolution
The 35 genes under positive selection in mouse included a
notable number of proteins involved in direct interactions
with one another (fig. 2) and in the same pathways: 5
genes in the complement cascade (C1ra, C1inh, C6, C8b,
and Cfh), 4 genes in the TLR signaling pathway (Irf5, Lbp,
Tlr3, and Trif), 3 genes in the Janus kinase-signal transducer
an activator of transcription (JAK-STAT) pathway (Stat2,
Il2rb, and Il4ra), and a 1 gene in the mitogen activated protein
kinase (MAPK) pathway signaling pathway (Ecsit). Of partic-
ular interest was the positive selection predicted to occur on
the Trif protein at the interaction interface with Tlr3 (fig. 2;
Oshiumi et al. 2003).
Ancestral Nodes Have Unique Subsets of Genes under
Positive Selection
As positive selection could have arisen within the ancestral
lineages separating modern human and mouse, we tested all
ancestral lineages across the Euarchontoglires clade (fig. 1),
that is, the ancestral primate, the most recent common an-
cestor (MRCA) of rat and mouse (murinae), and the MRCA of
all rodents in the data set.
We found 18 genes (11.56% of testable genes) with evi-
dence of species-specific positive selection in the ancestral
primate lineage. These genes clustered into three categories
relative to their function: Nod-like receptors (NLRP1, NLRP5,
and NLRP8), TRIM receptors (TRIM5 and TRIM25), and in-
terferon gamma receptors (IFNGR1 and IFNGR2; fig. 1 and
supplementary table S1, Supplementary Material online).
Within this set of genes there is one known protein–protein
interaction between IFNGR1 and IFNGR2 associated with the
JAK-STAT pathway (Kanehisa and Goto 2000). The JAK-STAT
pathway mediates cellular responses including proliferation,
differentiation, migration, apoptosis, and cell survival and is
the target for development of therapeutics for a variety of
immune disorders.
Analyses of the ancestral murinae and rodent branches
identified 18 (11.04%) and 8 (9.88%) genes, respectively, as
under species-specific positive selection (fig. 1 and supplemen-
tary table S1, Supplementary Material online). There was lim-
ited functional and pathway information on these genes and
there were no reports of direct protein–protein interactions in
either ancestral lineage. The C1inh and C9 genes from the
complement cascade featured in the murinae lineage with
sites under selection unique to that ancestral lineage. There
was also evidence for positive selection unique to the murinae
lineage in the TRAF6 protein, a gene known to interact with
the TLR signaling pathway (Kanehisa and Goto 2000).
Our results emphasize the heterogeneity in selective pres-
sures in the innate immune systems of different lineages and
species across the Euarchontoglires clade. These putative pos-
itively selected genes are prime targets for in vitro assessment
of functional consequences of mutating these residues.
Positively Selected Residues Map to Essential
Functional Domains and Are Predicted to
Affect Structural Stability
Assessment of the 35 genes under positive selection uniquely
in the mouse lineage identified clusters of positive selection in
the complement and the TLR signaling cascades (fig. 2a and b;
supplementary table S1, Supplementary Material online). To
determine the potential impact of positively selected residues
on immune function we employed data from SwissProt
(UniProt Consortium 2014). The residues under positive se-
lection in these proteins were concentrated in regions central
to function and in regions known to interact with one an-
other (fig. 2).
In the absence of in vitro functional assays for each of these
positively selected residues and genes, we performed predic-
tions on overall protein structure and stability based on in
silico structural modeling and rational mutagenesis to further
investigate these putative positively selected residues and to
predict their potential impact. The dynamic flexibility index
(dfi) measures the contribution of each residue to the overall
structural dynamics and stability of the protein (Gerek et al.
2013). The dfi approach uses perturbation response scanning
on a 3D elastic network model (Atilgan and Atilgan 2009;
Atilgan et al. 2010) to measure the spatial fluctuation of each
residue in response to perturbing residues along the peptide.
dfi values indicate the resilience of each residue to perturba-
tions, a low dfi indicates a residue essential for dynamic sta-
bility as they absorb the transfer of perturbation (i.e., these
residues are structurally inflexible) whereas high dfi implies
the residue is prone to perturbation (i.e., these residues are
structurally flexible; Gerek et al. 2013). dfi values are reported
to significantly correlate with known neutral variants display-
ing high dfi values and residues strongly linked with genetic
disease having low dfi values (Gerek et al. 2013). In compar-
ison to the solvent accessible surface area metric used to
assess functional significance, the correlation of dfi to biolog-
ical function has been reported to have a greater ability to
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discern functionally critical from noncritical sites (Gerek et al.
2013). In addition, in an analysis of 100 genes across 46
eukaryote genomes, dfi values were found to positively
correlate with the rate of evolution observed over
approximately 1 billion years of evolution showing that this
approach is robust to large evolutionary distances (Gerek
et al. 2013).
TLR3 was chosen for dfi analysis because it has a signature
of positive selection in mouse but not human, and also be-
cause TLR3 is well characterized and there are crystal struc-
tures for it’s ligand-binding ectodomain available for in silico
mutation (PDB identifier for Human TLR3 is 2A0Z, and for
Mouse is 3CIG). First, structural flexibility was assessed. We
assessed the dfi values for four well known human TLR3
Table 1. Sample of the Genes under Positive Selection in Human and Mouse and Their Parameter Estimates.
Gene Name Positively Selected Sites P-Value of Positively Selected Sites
Genes under positive selection in human
CARD6 264, 346, 382, 750, 767, 805, 818, 903, 916, 937, 998, 1010, and
1031
13 4 0.50, 0 4 0.95, 0 4 0.99
IRF3 119, 129, and 333 3 4 0.50, 0 4 0.95, 0 4 0.99
Genes under positive selection in mouse
Adipoq 25, 27, 29, and 82 4 4 0.50, 0 4 0.95, 0 4 0.99
Atg9a 634 and 662* 2 4 0.50, 1 4 0.95, 0 4 0.99
C1inh 332*, 365, 468, 479 4 4 0.50, 1 4 0.95, 0 4 0.99
C1ra 468, 520, 574, 631, 633, and 634* 6 4 0.50, 1 4 0.95, 0 4 0.99
C6 220, 233, 319, 353, 378, 408, 419, 430, 554, 655, 681, 703, 792,
and 930
14 4 0.50, 0 4 0.95, 0 4 0.99
C8b 242*, 263, 278, 383*, and 488 5 4 0.50, 2 4 0.95, 0 4 0.99
Card6 394, 501, and 702 3 4 0.50, 0 4 0.95, 0 4 0.99
Cd200 129 and 177 2 4 0.50, 0 4 0.95, 0 4 0.99
Cd63 31, 118, 143, 184*, 194, and 203 6 4 0.50, 1 4 0.95, 0 4 0.99
Cfh 209, 243, 474, 767, 1005, 1068, 1074, 1104, 1181, and 1227 10 4 0.50, 0 4 0.95, 0 4 0.99
Ecsit 10, 12, 75, 82, 176, 325, 330**, 348, and 371 9 4 0.50, 1 4 0.95, 1 4 0.99
Eif2ak2 136, 155, 181, 182*, 344, and 345 6 4 0.50, 1 4 0.95, 0 4 0.99
F12 45, 65, 166, 243**, and 454 5 4 0.50, 1 4 0.95, 1 4 0.99
Grn 18, 101, 198, 303, 375*, 382, 411, 549, and 597 9 4 0.50, 1 4 0.95, 0 4 0.99
Ifit2 191, 402, and 420 3 4 0.50, 0 4 0.95, 0 4 0.99
Il1rapl2 566, 628, and 666* 3 4 0.50, 1 4 0.95, 0 4 0.99
Il2rb 4, 13, 31, 55, 174, 202, 347*, 402, 418, 491, 496, and 516 12 4 0.50, 1 4 0.95, 0 4 0.99
Il4ra 47, 67, 308, 330, and 626 5 4 0.50, 0 4 0.95, 0 4 0.99
Irf5 232, 259, and 262 3 4 0.50, 0 4 0.95, 0 4 0.99
Lbp 24, 40 and 329 3 4 0.50, 0 4 0.95, 0 4 0.99
Lgals3 22, 92, 94, and 260 4 4 0.50, 0 4 0.95, 0 4 0.99
Lrrfip1 328, 449, 468, 480, and 571 5 4 0.50, 0 4 0.95, 0 4 0.99
Ltb4r1 53, 101, and 175 3 4 0.50, 0 4 0.95, 0 4 0.99
Nlrp14 77, 79*, 186, 212, 219, 254, 257, 263, 272, 281, 284, 291, 294, 315,
319, 333, 358, 393, 415, 424, 453, 465, 530, 549, 552, 553, 584,
613, 657, 679, 684, 685, 687, 696, 782, 810, 814, 829, 846, 848,
902, 908, 912, 931, 953, 956, 958, 978, 982, 984, and 986
51 4 0.50, 0 4 0.95, 0 4 0.99
Nlrp6 22, 25, 72, 77, 80, 81, 85, 96, 101, 113, 114, 190, 192, 251, 260**,
329, 344, 479, 488, 515, 553, 571, 628, 657, 727, 737, 739, 744,
771, 775*, 776, 793, 807, 865, 877, and 880
36 4 0.50, 2 4 0.95, 1 4 0.99
Oas2 55, 56, 139, 171, 199, 211, 221, 298, 481, 549, and 711 11 4 0.50, 0 4 0.95, 0 4 0.99
Plcg2 461 and 594* 2 4 0.50, 1 4 0.95, 0 4 0.99
Ptpn2 166, 206, 319, 321, and 329 5 4 0.50, 0 4 0.95, 0 4 0.99
Rnf31 203, 431, and 1025 3 4 0.50, 0 4 0.95, 0 4 0.99
Sirt1 107, 537, 698, and 701 4 4 0.50, 0 4 0.95, 0 4 0.99
Snap23 109, 133, and 197 3 4 0.50, 0 4 0.95, 0 4 0.99
Stat2 21, 130, 149, 157, 195, 205, 218, 354, 623*, 869, 871, 874, 876,
and 877
14 4 0.50, 1 4 0.95, 0 4 0.99
Tcf4 139 1 4 0.50, 0 4 0.95, 0 4 0.99
Tlr3 266, 297, and 603 3 4 0.50, 0 4 0.95, 0 4 0.99
Trif 18, 327, 338, 388, 482, 556, and 711 8 4 0.50, 0 4 0.95, 0 4 0.99
NOTE.—For each gene the positively selected sites are displayed and the associated posterior probability is indicated as follows: * 4 0.95, ** 4 0.99 and no asterisk implies
0.50< PP< 0.95.
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FIG. 1. Phylogeny of species included in this study and summary of lineage-specific positive selection results. The lineages that were tested for species-
specific selective pressure variation are highlighted. The number and percentage of genes displaying evidence of species-specific positive selection are
also shown.
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disease-associated residues: N284 and P554 that alter the ac-
tivity of TLR3 (Ranjith-Kumar et al. 2007), F303 which results
in TLR3 deficiency (Zhang et al. 2007), and L412 involved in
encephalopathy (Hidaka et al. 2006). All of these disease
associated sites were found to have low dfi values (Stenson
et al. 2003; fig. 3). Conversely, the positively selected residues
from mouse TLR3 (i.e., E266, Y297, and E604) and their coun-
terparts in human (i.e., N265, W296, and P602) had moderate
FIG. 2. Innate immune pathways incorporating multiple positively selected genes. The positively selected genes in (a) the complement system and (b)
the TLR signaling pathway are illustrated as darkened rectangles. Signaling cascades are depicted as arrows and inhibitors are depicted as blunt-ended
lines. Defined pathways and complexes are highlighted in gray boxes with the given name. (c) Positively selected sites of the complement system
alongside information on domain structure. Information on the function of these domains is also given.
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to high dfi values, indicating structural flexibility, perhaps this
flexibility is related to their role in ligand binding of the TLR3
ectodomain (fig. 3). Our results are consistent with disease-
associated sites being structurally inflexible in comparison to
other sites (Hurst and Smith 1999; Liu and Bahar 2012; Gerek
et al. 2013).
Next, we assessed the potential impact of the positively
selected residues on protein stability by calculating the
change in protein folding free energy (G) in the crystal
structures of the human and mouse TLR3 ectodomains
(fig. 3). G calculations are typically used to determine
if mutations are potentially deleterious due to protein
stability perturbations, with harmful mutations being
over a threshold (usually set to 4 1 kcal/mol; Yue et al.
2005). To determine the tolerance of each putative pos-
itively selected position to mutation, we calculated G
for all possible amino acid substitutions at each of these
specific positions. We did not predict a destabilizing effect
for the three positively selected residues in the ectodo-
main of mouse TLR3 (E266, Y297, and E603; fig. 3), indi-
cating that these positions in mouse are tolerant to
mutation and are structurally flexible directly supporting
the results from the dfi analysis. When we mutated the
homologous residues in human (N265, W296, and P602),
we found two sites (W296 and P602) exhibiting an effect
on folding stability. More specifically, of the 19 possible
mutations for the two positions W296 and P602, we ob-
serve destabilizing effects in 13 and 18 substitutions, re-
spectively (fig. 3). Substitutions of W296 and P602 exhibit
predicted changes in protein stability comparable to the
human disease-associated sites (i.e., N284, P554, F303, and
L412). Mutating randomly chosen residues in TLR3 pre-
dicted no such impact on protein stability (fig. 3). Taken
together, these data suggest that two of the positively
FIG. 3. dfi of human TLR3 ectodomain. Ribbon diagrams of the crystal structure of the TLR3 ectodomain of (a) human (PDB id: 2A0Z) and (b) mouse
(PDB id: 3CIG) colored with a spectrum of red–yellow–green–cyan–blue with respect to dfi. Red indicates the highest dfi values whereas blue indicates
the lowest values. (c) The stability change for all possible substitutions was computed for: the positively selected sites in mouse (E266, Y297, and E603),
their human homologs (N265, W296 and P602), known human disease-associated sites (N284, F303, L412, and P554; Stenson et al. 2003, and randomly
selected sites. Except for the randomly selected sites, sites have been colored and indicated on the respective ribbon diagrams.
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selected residues in mouse TLR3 and their homologous
positions in human TLR3 potentially contribute differ-
ently to overall protein stability in these two species.
The Majority of Positively Selected Residues Is Fixed
within Human and Mouse Species
Positive selection can rapidly drive advantageous alleles to
fixation within a population (Sabeti et al. 2006). Depending
on factors such as on the age of the event, effective popula-
tion size (Ne) of the species, and the strength of selection,
positively selected sites may be fully fixed within a population
or may have some degree of variability (Sabeti et al. 2006). We
sought to determine if the positively selected residues iden-
tified in human and mouse are fixed or variable in their re-
spective populations (table 2). We gathered all available single
nucleotide polymorphism (SNP) data for all positively se-
lected genes, that is, two human candidate genes and 27
mouse candidates. The majority (95–97%) of positively se-
lected sites in both human and mouse was entirely fixed in
their lineage. The exceptions were the CARD6 gene in human
and six mouse genes (C6, C8b, Ecsit, Il4ra, Nlrp14, and Stat2), in
total there were eight variable sites across these seven genes
(table 2). Of these eight variable positions, four sites had sub-
stitutions to the ancestral allele present at the homologous
position in other species, they were as follows: human CARD6
(G264E) and mouse Ecsit (S75L); Nlrp6 (R744K); and Stat2
(L874M). In addition, there were two substitutions at posi-
tively selected residues in mouse genes that resulted in amino
acids with similar physicochemical properties as the homol-
ogous position in another species: C6 (R554L) and Il4ra
(D626G; table 2).
The positively selected residues in human CARD6 and IRF9
genes were compared with the homologous positions in the
recently released Neanderthal genomes (Green et al. 2010),
and the same positively selected residues are fixed in
Neanderthal as in modern human.
Population Data Show No Ongoing Selective Sweep
in Modern Humans
To determine if our two positively selected genes from
human were under ongoing selective pressure, we tested
for evidence of reduced variability in 1 kb sliding windows
of allele frequency encompassing 100 kb up- and downstream
for each of the two genes. Variability and departure from
neutrality were measured in each window (Tajima 1989;
fig. 4). The analysis of CARD6 and IRF9 identified comparable
levels of variation for all windows assessed. The results of the
CARD6 and IRF9 analyses are consistent with a sweep to fix-
ation of the positively selected residues prior to the diver-
gence of human and Neanderthal, and a relaxation of
selective pressure in the current human population.
Discussion
We have shown that the innate immune systems of human
and mouse have experienced distinct species-specific selective
forces. Signatures of positive selection have been correlated
with alteration to protein function (Sawyer et al. 2005;
Loughran et al. 2012) and the identification of such distinct
patterns alongside known discordant immune responses pro-
vides the community with a set of potential molecular targets
for further testing.
The positively selected genes in mouse are components of
well-known innate immune pathways, and are involved up-
stream and downstream in these pathways. In pathways en-
riched for positively selected members (e.g., TLR signaling
pathways and complement system), more than half the com-
ponents are involved directly or indirectly with initiation (Cfh,
C1r, C1inh, Tlr3, and Lbp), indicating that upstream genes
may be more prone to positive selective pressure. Recent
studies have reported a relaxation in selective constraint as
you progress downstream through a pathway (Ramsay et al.
2009), whereas other reports detail patterns similar to those
presented here (Alvarez-Ponce et al. 2009). The enrichment
Table 2. Population Level Analysis of Positively Selected Sites in
Human and Mouse Genes.







Genes under positive selection specifically in the human lineage
CARD6 13 38 G264E
IRF9 3 9 None
Genes under positive selection specifically in the mouse lineage
Adipoq 4 9 None
Atg9a 1 3 None
C1ra 6 16 None
C6 14 53 R554L
C8b 5 36 M263I
Card6 3 4 None
Cd63 6 6 None
Cfh 10 8 None
Ecsit 9 1 S75L
Grn 9 16 None
Ifit2 3 14 None
Il1rapl2 3 11 None
Il4ra 5 51 F47S & D626G
Irf5 3 14 None
Lbp 2 33 None
Lgals3 4 15 None
Lrrfip1 5 49 None
Ltb4r1 3 16 None
Nlrp14 51 16 A613S
Nlrp6 36 53 None
Plcg2 1 51 None
Rnf31 3 24 None
Snap23 3 2 None
Stat2 14 58 L874M
Tcf4 1 20 None
Tlr3 3 4 None
Trif 7 3 None
NOTE.—Assessment of the fixation of positively selected sites was only possible on
the genes shown above. For each gene, the number of positively selected sites and
the number of coding SNPs tested are given. If a coding SNP within a positively
selected codon resulted in a nonsynonymous substitution, the resulting unfixed
variant is shown above as a mutation at their respective site (e.g., G264E).
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for positive selection that we observe at the start of the path-
ways is most likely because many of these genes directly in-
teract with pathogens (C6, C8, and Lbp), bind to pathogens
for immunological defense (Cfh), or are pathogen recognition
receptors (Tlr3) and are most likely under selective pressure
from the pathogen (Van Valen 1973). The absence of human-
specific positively selected genes within the TLR signaling
pathways and complement system may be due to the episo-
dic pattern of primate TLR evolution (Wlasiuk and Nachman
2010).
TLR3 is responsible for detecting double stranded RNA in
viral infections. The species-specific positive selection we de-
tected in TLR3 together with in silico predicted disparity in
stability between human and mouse residues suggests that
FIG. 4. Neutrality tests for positively selected genes in the human lineage. Sliding window analysis of Tajima’s D of the positively selected genes identified
in human. The analysis was conducted using a window size of 1 kb within 100 kb upstream and downstream of each gene. The 95% confidence interval
is shown as red highlighted region.
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there may be potential protein structural differences between
the human and mouse orthologs of TLR3. The positively se-
lected residues predicted for TLR3 are of particular interest
given the restricted antiviral role of human TLR3 in compar-
ison to mouse Tlr3, and LPS upregulation of Tlr3 in mouse but
not human macrophages (Ariffin and Sweet 2013). Further
investigation is warranted to determine if these sites in TLR3
have functional impact and if that is related to the observed
phenotypic discordance between human and mouse. The use
of in silico modeling approaches such as the dfi method ap-
plied here can help to prioritize targets from a selective pres-
sure analysis for in vitro testing.
The complement cascade is reported to neutralize herpes
simplex virus in rat, mouse, and human. However, comple-
ment activation proceeds uniquely for each species: via the
lectin pathway in mouse, via the alternative and lectin path-
ways in rat, and, in human via the classical pathway
(Wakimoto et al. 2002). The exclusive use of the lectin path-
way in mouse may in part be due to the species-specific
functional shift we have identified in the alternative and clas-
sical pathways. In response to Acanthamoeba infection, both
human and mouse are reported to initiate the complement
cascade by the alternative pathway leading to Acanthamoeba
binding with C9 of the membrane attack complex (MAC;
Pumidonming et al. 2011). In contrast, mouse MAC is
unable to lyse Acanthamoeba (Pumidonming et al. 2011).
Here, we show that the C6 and C8b proteins of the comple-
ment cascade are under positive selection in mouse but not
in human. These selected residues provide us with potential
targets for the discordant response between human and
mouse MAC. More generally, knowledge of the full plethora
of genes under positive selection in human, mouse, or their
ancestral lineages provide us with molecular markers that
may contribute to our understanding of the potential diffi-
culties in modeling human innate immunity (Mestas and
Hughes 2004; Seok et al. 2013).
Although signatures of positive selection were identified in
CARD6 and IRF9 in the lineage leading to modern human and
indeed Neanderthal, there is no evidence of an ongoing se-
lective sweep in modern human in these genes (Tajima 1989),
it is important to note that this approach is sensitive to the
age of the adaptive event with the outer limit for human of
approximately 250,000 years ago (Sabeti et al. 2006). The con-
servation of these positively selected residues between
modern human and Neanderthal may be due to shared an-
cestry dating these adaptive events to between approximately
400,000 and 600,000 years before present (ybp) (Scally and
Durbin 2012), alternatively an introgressive event (such as
that reported for the HLa locus (Abi-Rached et al. 2011))
would date the event between 40,000 and 400,000 ybp
(Pinhasi et al. 2011).
The majority (96%) of positively selected sites was fixed in
the modern human or mouse populations. However, it is
important to note that the mouse population data are
based on 21 artificially selected laboratory mouse strains,
and therefore does not represent true population structure
(Keane et al. 2011). The single unfixed positively selected site
in human was position G264E of CARD6. This replacement
SNP (rs61757657) is documented in only 3% of Africans and
1% of Americans (2% of Puerto Ricans; Kinsella et al. 2011;
Abecasis et al. 2012). Therefore, our predictions of positive
selection in human and mouse are for residues that we de-
termined to be at high frequency in these species.
Our novel candidates for positive selection have direct
utility for the study of human and mouse innate immunology.
Such applications of evolutionary theory to immunology have
the potential to contribute to more precise modeling of the
human immune response in the future.
Materials and Methods
Generating the Data Set for Analysis
The innate immune data set consisted of 725 human innate
immune response genes downloaded from InnateDB (Lynn
et al. 2008). Ortholog identification was achieved using stan-
dalone BLASTp (v2.2.23+; Altschul et al. 1990) on the canon-
ical transcripts of 21 high coverage (4 6) genomes:
chicken, chimpanzee, cow, dog, elephant, fugu, gorilla,
guinea pig, horse, human, marmoset, mouse, opossum, orang-
utan, pig, platypus, rabbit, rat, xenopus, zebra finch, and zeb-
rafish. Genomes were downloaded from Ensembl Gene 60 on
Ensembl BioMart (Kinsella et al. 2011). Orthologous groups
were identified utilizing a threshold of less than e-150 and
above 85% sequence alignment length to ensure high-quality
alignments. Families were only analyzed if they contained six
or more members.
Sequence Alignment and Selection
Amino acid multiple sequence alignment (MSA) was carried
out using MUSCLE (v3.8.31; Edgar 2004) and PRANK
(v100802; Loytynoja and Goldman 2005). The alignments
from MUSCLE and PRANK were compared using MetAl
(v1.1.0; Blackburne and Whelan 2012) and NoRMD (v1.2;
Thompson et al. 2001), and a single alignment was selected
for each family.
Protein Model Selection
Substitution models were selected for the MSA based on the
results of ProtTest 3.0 (Darriba et al. 2011). Matrices were also
assayed in the presence of invariable sites (+I), variable rate
categories (+G), or a combination of these two factors (+I+G).
The model of best fit for each MSA was chosen using the
resulting Bayesian information criterion scores ([Darriba et al.
2011] and references therein).
Phylogenetic Reconstruction
Phylogenetic reconstruction was carried out using MrBayes
(Ronquist and Huelsenbeck 2003). MSA input was provided
by the results of either MetAl or NoRMD using the substitu-
tion model provided by ProtTest (Thompson et al. 2001;
Darriba et al. 2011; Blackburne and Whelan 2012). For each
MSA, four Markov chain Monte Carlo chains were run for a
minimum of 106 generations or until convergence was
reached. Chains were sampled every 200 generations with a
burn-in fraction of 0.25. Under these settings a minimum of
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3,750 samples were assayed for a posterior probability distri-
bution for each gene alignment.
Selective Pressure Analysis
Selective pressure analyses were performed utilizing codeML
from the PAML software package (v4.4e; Yang 2007). CodeML
examines nested codon-based models of evolution in a max-
imum likelihood framework to determine the ratio of non-
synonymous substitutions per nonsynonymous site (Dn) to
synonymous substitutions per synonymous site (Ds), or !
(Yang 2007). We employed branch-site specific models be-
cause we wished to scan for positive selection that is unique
to a specific foreground lineage/clade and that is not present
elsewhere on the tree (Yang and dos Reis 2011). Our analysis
uses in-house software for implementing LRTs (available from
authors on request). The LRT test statistic approximates the
chi-squared (2) distribution critical value with degrees of
freedom equal to the number of additional free parameters
in the alternative model.
If models passed LRT and positive selection is inferred, the
posterior probability of the positively selected site is estimated
using two calculations: Na€ıve Empirical Bayes (NEB) or Bayes
Empirical Bayes (BEB; Yang 2007). If both BEB and NEB are
predicted, we utilized the BEB results as they have been re-
ported to be more robust ([Yang 2007] and references
therein).
Detection of Recombination
We tested if recombination had occurred in the genes of the
single gene orthologous data set using RDP3 (Martin et al.
2010). This includes the following methods for detecting re-
combination: BOOTSCAN, GENECONV, MAXCHI,
CHIMAERA, SISCAN, and 3SEQ (see [Martin et al. 2010]
and references therein). Evidence of recombination was re-
ported if an event was significant for a phylogenetic-based
method (BOOTSCAN or SISCAN) as well as a substitution-
based method (CHIMAERA, MAXCHI, GENECONV, or 3SEQ)
(see [Martin et al. 2010] and references therein).
Structural Analysis of TLR3
We modeled 3D structures of mouse and human TLR3 ecto-
domain. We obtained 100% sequence identity between the
target sequences and mouse (PDB id: 3CIG) and human (PDB
id: 2A0Z) template structures. After having modeled struc-
tures, we first computed the dfi (Gerek et al. 2013) that
quantifies the dynamic properties of individual residues in
any protein structure and then the stability change caused
by mutating each positively selected site in the structure
(Gerek et al. 2013). Overall, due to 3D structure and the res-
idue interaction network within a protein, some positions are
more susceptible to these perturbations, showing high fluc-
tuation responses and high dfi values, whereas other positions
with low dfi values are stable and do not deviate significantly
from their original position upon perturbation. Therefore,
higher dfi means greater chance that this is a nonfunction-
altering mutation.
The stability change is measured by calculating the protein
folding free energy (G). G value for each amino acid
substitution (mutant) is calculated from GmutantGwt
where Gwt is the wild type free energy of unfolding.
To compute the G values for each amino acid substitu-
tion, we applied the FoldX method (Guerois et al. 2002;
Schymkowitz et al. 2005) that utilizes empirical potential
combining both physical force fields and free parameter
fitted with known experimental data. If the value of G
is greater than 0, the mutation has a destabilizing effect on the
protein structure, while G< 0, the mutation is stabilizing.
In our analysis, we used 1 kcal/mol as a threshold. First, we
computed the stability change of positively selected residues
in the mouse structure and then we selected positively se-
lected sites in the human sequence from the alignment in-
formation. Finally, we estimated G for all possible amino
acid substitutions in the human structure. In addition, we
computed stability changes corresponding to sites that
cause disease in humans. These disease-associated sites
were obtained from the Human Gene Mutation Database
(Stenson et al. 2003). To determine if there are patterns of
“protein stability” are unique to positively selected residues
compared with all other residues in the protein including
disease sites, we estimated the G for all possible amino
acid substitutions of randomly selected sites as well as all
positively selected and known disease-associated sites.
Fixation of Positively Selected Sites in Population SNP
Data
To determine the frequency at which positively selected sites
were fixed within the human population, we downloaded
validated SNPs for protein-coding regions from Ensembl
Biomart (Ensembl Variation 72; Kinsella et al. 2011). Using
in-house software we mapped a total of 559 SNPs onto the
protein-coding regions of 26 positively selected innate
immune genes (3 human and 23 mouse). We also mapped
our putative positively selected sites to this alignment.
Assessing Positively Selected Genes for Evidence of
Selection within Human Population Data
To determine if population data corroborated the species-
level findings for positive selection in human lineage, we
downloaded variation data from the 1000 Genomes Project
website, with each individual consisting of two chromosomal
samples (Abecasis et al. 2012). To establish evidence of a se-
lective sweep, we created population alignments for our
human positively selected genes, including 100 kb upstream
and downstream DNA (where possible). Using DnaSP
(Librado and Rozas 2009) we calculated Tajima’s D (Tajima
1989) and nucleotide diversity (Nei and Li 1979) for each gene
in 1 kb windows. To determine the significance of Tajima’s D,
10,000 coalescence simulations were conducted for each gene
(Hudson 2002).
Supplementary Material
Supplementary table S1 is available at Molecular Biology and
Evolution online (http://www.mbe.oxfordjournals.org/).
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